Product Information

ASPIRIN EC 81 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0140 per EA under NDC 57237034910. Its NADAC has been published 43 times since Jan 28, 2026.

ASPIRIN EC 81 MG TABLET

Aspirin
$0.0140per EA
OTC

Strength

81 mg/1

NDC

57237034910

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ASPIRIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

7/9/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor

Price Statistics

The NADAC for ASPIRIN EC 81 MG TABLET has been published 43 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0140 per EA
All-time high$0.0147 (May 13, 2026)
All-time low$0.0140 (Nov 18, 2026)
52-week high$0.0147
52-week low$0.0140
Median price$0.0144
Average price$0.0144
Largest weekly change-2.5% (Sep 23, 2026)
Weeks tracked43
Tracking sinceJan 28, 2026

Price History

1W

-1.1%

1M

-1.1%

3M

-3.4%

6M

-2.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.9%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ASPIRIN EC 81 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN EC 81 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0140 per EA (NDC 57237034910), effective Nov 18, 2026.

How has the price of ASPIRIN EC 81 MG TABLET changed over time?

Over the history we have for it, the NADAC for ASPIRIN EC 81 MG TABLET has held within roughly two percent of its current level. It has been tracked across 43 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for ASPIRIN EC 81 MG TABLET?

Since Jan 28, 2026, the NADAC for ASPIRIN EC 81 MG TABLET has ranged from a low of $0.0140 (Nov 18, 2026) to a high of $0.0147 (May 13, 2026), with a median of $0.0144 per EA.

Are there cheaper alternatives to ASPIRIN EC 81 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MINIPRIN EC 81 MG TABLET, is $0.0118 per EA — about 16% below ASPIRIN EC 81 MG TABLET.

Who manufactures ASPIRIN EC 81 MG TABLET?

ASPIRIN EC 81 MG TABLET (NDC 57237034910) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.